Down-regulation of RB1 and TP53 as potential predicting biomarkers for castration-resistant prostate cancer (CRPC): Indonesian retrospective cohort study

INTRODUCTION: Androgen deprivation therapy (ADT) has remained the first line strategy for treatment of advanced prostate cancers. Despite the profound efficacy of ADT in preventing clinical remission, 30–50% of advanced prostate cancer will develop resistance to hormonal deprivation therapy. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Soerohardjo, Indrawarman, Widodo, Irianiwati, Heriyanto, Didik Setyo, Zulfiqqar, Andy, Anwar, Sumadi Lukman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704423/
https://www.ncbi.nlm.nih.gov/pubmed/33299560
http://dx.doi.org/10.1016/j.amsu.2020.11.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704423/
https://www.ncbi.nlm.nih.gov/pubmed/33299560
http://dx.doi.org/10.1016/j.amsu.2020.11.017

Ejemplares similares